Abstract

During the past decade there has been an increase in funding for research capacity building in Africa. Two major European programmes are at a turning point: the Wellcome Trust's African Institutions Initiative is about to end, while their new initiative, DELTAS Africa,1 will be launched later this year. The European Union's Seventh Framework Programme (FP7) is ending, superseded by Horizon 2020,2 with the transition of some research areas that are important to Africa into the expanded second phase of the European and Developing Countries Clinical Trials Partnership.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call